BSECompany Update2d ago · 29 Jul 2026, 06:45 pm
Change in Senior Management personnel of the Company
Jagsonpal Pharmaceuticals Ltd · 507789
✦ AI SummaryMgmt Change
Jagsonpal Pharmaceuticals Ltd has announced changes in senior management personnel, designating Mr. Balmukund Keshav as Deputy General Manager (Information Technology) and Mr. Sanjay Singhal as General Manager (CQA & Regulatory Affairs), effective July 29, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Change in Management
Attachments (1)
📄pdf
Download →
c1c28c4b-88e1-44d8-b3ff-8ae68d27e031.pdf
View document text
July 29, 2026
The Department of Corporate Services- Listing The Department of Corporate Services- Listing
BSE Ltd, National Stock Exchange of India Ltd
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G,
Dalal Street Bandra Kurla Complex,
Mumbai-400 001 Bandra (E) Mumbai – 400 051
Scrip Code: 507789 Symbol: JAGSNPHARM
Subject: Change in Senior Management Personnel of the Company - Disclosure under Regulation 30 of Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”)
Dear Sir/ Madam,
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015, read with Part A of Schedule III thereto, we wish to inform that consequent to internal restructuring the
following individuals have been designated as Senior Management Personnel of the Company effective July 29, 2026:
1. Mr. Balmukund Keshav, Deputy General Manager (Information Technology).
2. Mr. Sanjay Singhal, General Manager- (CQA & Regulatory Affairs).
Details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with
SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 are enclosed as Annexure A.
We request you to take the above on record.
Thanking you,
For Jagsonpal Pharmaceuticals Limited
Pratham Rawal
Company Secretary & Compliance officer
Annexure-A
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule
Ill of the Listing Regulations read with SEBI master circular HO/49/14/14(7)2025-CFD-POD2/l/3762/2026 dated January 30,
2026 related to appointment as mentioned below:
S. Particulars Mr. Balmukund Keshav Mr. Sanjay Singhal
No. DGM – (Information Technology) General Manager (CQA & Regulatory Affairs)
1. Reason for Change viz Designated as Senior Management Designated as Senior Management Personnel.
appointment, Personnel
re-appointment, resignation,
removal, death
or otherwise;
2. Date of appointment 29th July, 2026 29th July, 2026
Cessation & term of
appointment Term of Appointment:- Term of Appointment:-
Not Applicable Not Applicable
3. Brief Profile Mr. Balmukund Keshav holds an MBA in Sanjay Singhal is a Pharmacy professional
Information Systems from Sikkim Manipal with Masters Degree in Pharmaceutical
University and a B.Sc. (Chemistry Hons.) science from Birla Institute of Technical
from Magadh University. studies, Pilani (BITS PILANI).
He has over 29 years of experience in IT Mr. Sanjay Singhal has 31 years’ experience
leadership and currently serves as Deputy in pharmaceutical industry, with
General Manager – IT at Jagsonpal comprehensive expertise across the entire
Pharmaceuticals Ltd. all pharmaceutical divisions including
manufacturing, supply chain, Quality and
During his 17-year tenure with Jagsonpal, regulatory affairs.
he has led digital transformation, ERP
implementation, ITGC audits, and He has been associated with the Company
enterprise infrastructure management. since 11 March, 2020.
His expertise includes IT governance, risk
and information security, vendor Mr. Sanjay Singhal is also Government
management, and digital process approved technical person for all dosage
automation. forms across manufacturing and analytical
divisions.
4. Disclosure of relationships Not Applicable Not Applicable
between Directors (In case of
appointment of Director)
5. Information as required Not Applicable Not Applicable
pursuant to BSE Circular
with ref. no. LIST/ COMP/
14/2018- 19 and the
National Stock Exchange of
India Ltd with ref. no. NSE/
CML/2018/24, both dated
June 20, 2018.